Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

LivaNova Reports Second-Quarter 2022 Results
LivaNova Reports Second-Quarter 2022 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2022.



Financial Summary and Highlights1




  • Revenue

Humana Foundation Donates $500,000 to Support Recovery in Wake of Devastating Flooding
Humana Foundation Donates $500,000 to Support Recovery in Wake of Devastating Flooding


The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, is donating $500,000 towards relief and recovery efforts for those impacted by torrential rains and

Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis
Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis


Agilent Technologies Inc. (NYSE: A) today announced it has acquired Polymer Standards Service GmbH (PSS), a provider of solutions in the field of polymer characterization. PSS specializes in

Agilent Announces Thought Leader Award to Gerhardt Attard at University College London (UCL)
Agilent Announces Thought Leader Award to Gerhardt Attard at University College London (UCL)


Agilent Technologies Inc. (NYSE: A) today announced that Professor Gerhardt Attard has been selected to receive a prestigious Agilent Thought Leader Award. Prof Attard is a John Black Charitable

Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes
Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, and NHS England today announced the availability of the easy to use Dexcom ONE

Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes
Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, and NHS England today announced the availability of the easy to use Dexcom ONE

Humana ranked No. 1 among health insurers for Customer Experience
Humana ranked No. 1 among health insurers for Customer Experience


For two years in a row, Humana ranked No. 1 among health insurers for customer experience (CX) quality in Forrester’s proprietary 2022 U.S. Customer Experience Benchmark survey. The ranking was

Dexcom Reports Second Quarter 2022 Financial Results
Dexcom Reports Second Quarter 2022 Financial Results


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2022.



Second Quarter 2022 Financial Highlights:




  • Revenue grew 17% versus the same

Dexcom Reports Second Quarter 2022 Financial Results
Dexcom Reports Second Quarter 2022 Financial Results


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2022.



Second Quarter 2022 Financial Highlights:




  • Revenue grew 17% versus the same

Acadia Healthcare Reports Second Quarter 2022 Results and Raises 2022 Guidance
Acadia Healthcare Reports Second Quarter 2022 Results and Raises 2022 Guidance


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2022.



Second Quarter Highlights




  • Revenue totaled $651.7 million, an

Agilent 2022 Early Career Professor Award Presented to Stefanos Nikolaidis:
Agilent 2022 Early Career Professor Award Presented to Stefanos Nikolaidis


Agilent Technologies Inc. (NYSE: A) announced today that Stefanos Nikolaidis Ph.D. has received the Agilent 2022 Early Career Professor Award. Dr. Stefanos Nikolaidis is an Assistant Professor of

DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
Simulations Plus Presented New Scientific Developments at PAGE 2022
Simulations Plus Presented New Scientific Developments at PAGE 2022


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the presentation of five scientific

Agilent ESG Report Highlights Plans and Progress to Ensure Future Sustainable Growth:
Agilent ESG Report Highlights Plans and Progress to Ensure Future Sustainable Growth


Agilent Technologies Inc. (NYSE: A) today released its inaugural Environmental, Social, and Governance (ESG) report, including the company’s first TCFD climate risk report; details on its

Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer


Simulations Plus (Nasdaq: SLP) is celebrating 25 years in business and continuing the commitment to improve public health through innovative solutions with a $25,000 donation to St. Jude Children’s

DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Humana Hiring 300 Seasonal Remote Positions
Humana Hiring 300 Seasonal Remote Positions


Leading health and well-being company Humana Inc. (NYSE: HUM) announced it is looking to hire about 300 seasonal Enrollment Representatives for nationwide work-from-home positions.



Humana’s

STAAR Surgical to Report Second Quarter Results on August 10, 2022
STAAR Surgical to Report Second Quarter Results on August 10, 2022


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release

DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award: https://unsplash.com/photos/WUehAgqO5hE
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award


Agilent Technologies Inc. (NYSE: A) today announced the company’s Certified Pre-Owned Instruments Program received a Top Project award for achieving outstanding results in reducing waste. The award

Agilent to Announce Third-Quarter Fiscal Year 2022 Financial Results August 16
Agilent to Announce Third-Quarter Fiscal Year 2022 Financial Results August 16


Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16. The company will